Sarepta Therapeutics Inc (SRPT)
115.54
-0.97
(-0.83%)
USD |
NASDAQ |
Apr 19, 16:00
117.00
+1.46
(+1.26%)
After-Hours: 20:00
Sarepta Therapeutics Cash from Operations (Quarterly): -54.66M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -54.66M |
| September 30, 2023 | -114.71M |
| June 30, 2023 | -122.23M |
| March 31, 2023 | -209.40M |
| December 31, 2022 | -92.39M |
| September 30, 2022 | -64.96M |
| June 30, 2022 | -66.82M |
| March 31, 2022 | -101.18M |
| December 31, 2021 | -29.33M |
| September 30, 2021 | -124.33M |
| June 30, 2021 | -109.15M |
| March 31, 2021 | -180.37M |
| December 31, 2020 | -174.54M |
| September 30, 2020 | -238.19M |
| June 30, 2020 | -107.60M |
| March 31, 2020 | 627.79M |
| December 31, 2019 | -163.80M |
| September 30, 2019 | -67.43M |
| June 30, 2019 | -79.00M |
| March 31, 2019 | -146.23M |
| December 31, 2018 | -122.42M |
| September 30, 2018 | -113.32M |
| June 30, 2018 | -117.25M |
| March 31, 2018 | -35.67M |
| December 31, 2017 | -31.06M |
| Date | Value |
|---|---|
| September 30, 2017 | -57.90M |
| June 30, 2017 | -85.15M |
| March 31, 2017 | -57.89M |
| December 31, 2016 | -81.23M |
| September 30, 2016 | -60.62M |
| June 30, 2016 | -43.28M |
| March 31, 2016 | -60.69M |
| December 31, 2015 | -31.27M |
| September 30, 2015 | -46.31M |
| June 30, 2015 | -28.53M |
| March 31, 2015 | -43.35M |
| December 31, 2014 | -25.45M |
| September 30, 2014 | -35.32M |
| June 30, 2014 | -39.50M |
| March 31, 2014 | -28.26M |
| December 31, 2013 | -17.82M |
| September 30, 2013 | -19.88M |
| June 30, 2013 | -12.00M |
| March 31, 2013 | -14.99M |
| December 31, 2012 | -7.158M |
| September 30, 2012 | -7.805M |
| June 30, 2012 | -5.682M |
| March 31, 2012 | -9.049M |
| December 31, 2011 | -5.648M |
| September 30, 2011 | -7.523M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-238.19M
Minimum
Sep 2020
627.79M
Maximum
Mar 2020
-77.49M
Average
-107.60M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| PTC Therapeutics Inc | -100.29M |
| Vertex Pharmaceuticals Inc | 234.60M |
| Regenxbio Inc | -40.76M |
| CytomX Therapeutics Inc | -21.96M |
| Apellis Pharmaceuticals Inc | -97.88M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -64.36M |
| Cash from Financing (Quarterly) | 1.943M |
| Free Cash Flow | -588.34M |
| Free Cash Flow Per Share (Quarterly) | -0.7102 |
| Free Cash Flow to Equity (Quarterly) | -74.94M |
| Free Cash Flow to Firm (Quarterly) | -73.70M |
| Free Cash Flow Yield | -5.51% |